期刊文献+

粘多糖病ⅢA型合并癫癇1例报道及文献复习 被引量:1

Mucopolysaccharidosis type ⅢA(sanfilippo syndrome type A) with epilepsy:case report and review of literature
原文传递
导出
摘要 目的探讨粘多糖病ⅢA型(MPS ⅢA)合并癫癇发作的临床表现、脑电图特征及治疗。方法报道1例MPS ⅢA合并有癫癇发作患者的临床资料并复习相关文献。结果本例患者6岁半时确诊粘多糖病IIIA型(MPS ⅢA),3岁时首次癫癇发作,9岁后发作频繁(1~2次/d),同时睡眠时间减少、易兴奋、性格急躁,癫癇发作表现为全面性强直-阵挛发作并喉部发声,其发作间期脑电图特征为双侧前头部(额极-额-前颞区)低-中波幅慢波假节律样发放伴多量不典型三相波发放,初期单用妥泰疗效不佳,合用苯巴比妥治疗后发作得到有效控制,睡眠和情绪障碍改善明显。结论粘多糖病ⅢA型(MPS ⅢA)合并癫癇发作患儿伴有睡眠、情绪障碍,发作间期脑电图具有一定的特征性,妥泰联合苯巴比妥可有效控制患儿癫癇发作,并在一定时期内改善患儿睡眠和情绪。 Objective To discuss the clinical symptom, electroencephalographic features and treatment of Mucopolysaccharidosis Type ⅢA (MPS ⅢA, Sanfilippo Syndrome Type A) with epileptic seizure. Methods We reported a case of MPS ⅢA with epileptic seizure including its all clinical data. Results The patient had been diagnosed with MPS ⅢA when he was 6. 5 years old. Seizures appeared in his 3-year-old and became more frequently after his 9-year-old (1- 2 times per day). The seizure was generalized tonic-clonic one ac- companying with throaty vocalization. Other main symptoms included less sleeping time, more excitement and irritability. The interictal electroencephalogram (EEG) showed an anterior slow wave rhythm with lots of a- typical triphasic waves. Topiramate was first prescribed to control seizure with some improvement. Then Phe- nobarbitone was added and the effect appeared well, meanwhile his sleep and emotions disorders got better. Conclusions Patients of MPS ⅢA with epileptic seizure always have sleeping and emotional disorders with some special features in EEG. Seizure could be safely controlled by Topamax in combination with Phenobarbi- tone, and the sleeping and emotional disorders could be improved at the same time.
出处 《卒中与神经疾病》 2013年第2期106-108,126,共4页 Stroke and Nervous Diseases
关键词 粘多糖病ⅢA型 癫癇发作 脑电图 Mucopolysaccharidosis Type ⅢA Epileptic seizure Electroencephalogram
  • 相关文献

参考文献15

  • 1Valstar MJ, Neijs S, Bruggenwirth HT, et al. Mucopolysaccha- ridosis type IIIA: clinical spectrum and genotype-phenotype cor- relations. Ann Neurol,2010,68(6):876-887.
  • 2Perkins KJ, Byers S, Yogalingam G, et al. Expression and char- acterization of wild type and mutant recombinant human sulfami- dase. Implications for Sanfilippo (Mucopolysaccharidosis IIIA) syndrome. J Biol Chem, 1999,274(52) :37193-37199.
  • 3Poorthuis BJ, Wevers RA, Kleijer WJ, et al. The frequency of lysosomal storage diseases in The Netherlands. Hum Genet, 1999,105(1-2) : 151-156.
  • 4Meikle PJ, Hopwood JJ, Clague AE, et al. Prevalence of lysoso- real storage disorders. Jama, 1999,281(3) :249-254.
  • 5Meyer A; Kossow K, Gal A, et al. Scoring evaluation of the natural course of mucopolysaceharidosis type IIIA (Sanfilippo syndrome type A). Pediatrics, 2007,120(5):e1255-1261.
  • 6Tylki-Szymanska A, Metera M. Precocious puberty in three boys with Sanfilippo A (mucopolysaccharidosis III A). J Pediatr Endocrinol Metab, 1995,8 ( 4 ):291-293.
  • 7Concolino D, Muzzi G, Pisaturo L, et al. Precocious puberty in Sanfilippo IliA disease: diagnosis and follow-up of two new ca- ses. Eur J Med Genet, 2008,51 (5) : 466-471.
  • 8Manzi B, Loizzo AL, Giana G, et al. Autism and metabolic dis- eases. J Child Neurol, 2008,23(3):307-314.
  • 9Valstar MJ, Marchal JP, Grootenhuis M, et al. Cognitive devel- opment in patients with Mueopolysaccharidosis type III (Sanfilip- po syndrome). Orphanet J Rare Dis,2011,6:43.
  • 10Mariotti P, Della Marca G, Iuvone L, et al. Sleep disorders in Sanfilippo syndrome: a polygraphic study. Clin Electroeneepha- logr, 2003,34 (1) : 18-22.

同被引文献19

  • 1Am P, Bruce lA, Wraith lE. et al. Airway-related symptoms and surgeries in patients with mucopolysaccharidosis 1[1). Ann Otol Rhinol Laryngol, 2015,124:198-205.
  • 2Hendriksz Cl . Berger KI, Giugliani R, et aI. International guidelines for the management and treatment of Morquio A syndrome[l). Am 1 Med Genet A. 2015, 167A:11-25.
  • 3Muenzer 1. Overview of the mucopolysaccharidoses[J]. Rheumatology (Oxford), 2011, 50 SuppI5:v4-12.
  • 4Gtiniilda§ B, Yilmaz T, Sivri HS, et al. Mucopolysaccharidosis: Otolaryngologic findings, obstructive sleep apnea and accumulation of glucosaminoglycans in lymphatic tissue of the upper airway[J]. Int J Pediatr Otorhinolaryngol, 2014, 78:944-949.
  • 5Pelley CJ, Kwo J, Hess DR. Tracheomalacia in an adult with respiratory failure and Morquio syndrome[J]. Respir Care, 2007, 52: 278-282.
  • 6Mesolella M, Cimmino M, Cantone E, et al. Management of otolaryngological manifestations in mucopolysaccharidoses: our experience[J]. Acta Otorhinolaryngol Ital, 2013, 33:267-272.
  • 7Jeong HS, Cho DY, Ahn KM. Complications of tracheotomy in patients with mucopolysaccharidoses type II (Huntersyndrome)[J]. Int J Pediatric Otorhinolaryngol, 2006, 70:1765-1769.
  • 8Walker RW, Colovic V, Robinson DN, et al. Postobstructive pulmonary oedema during anaesthesia in children with mucopolysaccharidoses[J]. Paediatr Anaesth, 2003, 13:441-447.
  • 9Frawley G, Fuenzalida D, Donath S. A retrospective audit of anesthetic techniques and complications in children with mucopolysaccharidoses[J]. Paediatric Anaesth, 2012, 22:737-744.
  • 10Charrow J, Alden TD, Breathnach CA. Diagnostic evaluation, monitoring, and perioperative management of spinal cord compression in patients with Morquio syndrome[J]. Mol Genet Metab, 2015,114:11- 18.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部